In this Drug Design, 2020 Conference covers the hypothetical foundation and philosophies of valuable procedures of cheminformatics and bioinformatics that can be applied for Drug repurposing. Our Congress is aiming to Offers deep discussions on contextual investigations identifying with the in silico demonstrating of FDA-affirmed drugs for the revelation of antifungal, anticancer, antiplatelet specialists, and for medicating treatments against sicknesses. In-silico medicate structure aptitudes are utilized in nanotechnology, molecular biology, biochemistry and so forth.
Sub Tracks
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
